These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25811296)
1. Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy. Osti MF; Nicosia L; Agolli L; Gentile G; Falco T; Bracci S; Di Nardo F; Minniti G; De Sanctis V; Valeriani M; Maglio M; Borro M; Simmaco M; Enrici RM Am J Clin Oncol; 2017 Dec; 40(6):535-542. PubMed ID: 25811296 [TBL] [Abstract][Full Text] [Related]
2. Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt. Formica V; Benassi M; Del Vecchio Blanco G; Doldo E; Martano L; Portarena I; Nardecchia A; Lucchetti J; Morelli C; Giudice E; Rossi P; Anselmo A; Sileri P; Sica G; Orlandi A; Santoni R; Roselli M Med Oncol; 2018 May; 35(6):83. PubMed ID: 29721745 [TBL] [Abstract][Full Text] [Related]
3. Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant. Schirmer MA; Mergler CP; Rave-Fränk M; Herrmann MK; Hennies S; Gaedcke J; Conradi LC; Jo P; Beissbarth T; Hess CF; Becker H; Ghadimi M; Brockmöller J; Christiansen H; Wolff HA Int J Radiat Oncol Biol Phys; 2012 May; 83(1):149-57. PubMed ID: 22000747 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms and mutations in GSTP1, RAD51, XRCC1 and XRCC3 genes in breast cancer patients. Al Zoubi MS; Zavaglia K; Mazanti C; Al Hamad M; Al Batayneh K; Aljabali AAA; Bevilacqua G Int J Biol Markers; 2017 Jul; 32(3):e337-e343. PubMed ID: 28315507 [TBL] [Abstract][Full Text] [Related]
5. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413 [TBL] [Abstract][Full Text] [Related]
6. Association of Gupta P; Sambyal V; Guleria K; Uppal MS; Sudan M Genet Test Mol Biomarkers; 2023 Jul; 27(7):205-214. PubMed ID: 37522793 [No Abstract] [Full Text] [Related]
7. Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoea. Reis T; Khazzaka E; Welzel G; Wenz F; Hofheinz RD; Mai S Radiat Oncol; 2015 Jan; 10():30. PubMed ID: 25636703 [TBL] [Abstract][Full Text] [Related]
8. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215 [TBL] [Abstract][Full Text] [Related]
10. Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. Falvo E; Strigari L; Citro G; Giordano C; Arcangeli S; Soriani A; D'Alessio D; Muti P; Blandino G; Sperduti I; Pinnarò P BMC Cancer; 2011 Jul; 11():291. PubMed ID: 21749698 [TBL] [Abstract][Full Text] [Related]
11. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients. Lamas MJ; Duran G; Gomez A; Balboa E; Anido U; Bernardez B; Rana-Diez P; Lopez R; Carracedo A; Barros F Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):138-44. PubMed ID: 21167658 [TBL] [Abstract][Full Text] [Related]
12. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra. Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056 [TBL] [Abstract][Full Text] [Related]
13. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer. Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076 [TBL] [Abstract][Full Text] [Related]
15. High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer. Wolff HA; Gaedcke J; Jung K; Hermann RM; Rothe H; Schirmer M; Liersch T; Herrmann MKA; Hennies S; Rave-Fränk M; Hess CF; Christiansen H Strahlenther Onkol; 2010 Jan; 186(1):30-35. PubMed ID: 20082185 [TBL] [Abstract][Full Text] [Related]
16. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Damaraju S; Murray D; Dufour J; Carandang D; Myrehaug S; Fallone G; Field C; Greiner R; Hanson J; Cass CE; Parliament M Clin Cancer Res; 2006 Apr; 12(8):2545-54. PubMed ID: 16638864 [TBL] [Abstract][Full Text] [Related]
17. [Impact of CCND1 A870G polymorphism on acute adverse events in postoperative rectal cancer patients treated with adjuvant concurrent chemoradiotherapy]. Qiao Y; Ren H; Huang Y; DU ZL; Yu DK; Jin J; Li YX; Lin DX; Tan W Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):268-72. PubMed ID: 23985254 [TBL] [Abstract][Full Text] [Related]
18. XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer. Grimminger PP; Brabender J; Warnecke-Eberz U; Narumiya K; Wandhöfer C; Drebber U; Bollschweiler E; Hölscher AH; Metzger R; Vallböhmer D J Surg Res; 2010 Nov; 164(1):e61-6. PubMed ID: 20863523 [TBL] [Abstract][Full Text] [Related]
19. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. Dzhugashvili M; Luengo-Gil G; García T; González-Conejero R; Conesa-Zamora P; Escolar PP; Calvo F; Vicente V; Ayala de la Peña F Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):595-602. PubMed ID: 25304949 [TBL] [Abstract][Full Text] [Related]
20. Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients. Smith JJ; Wasserman I; Milgrom SA; Chow OS; Chen CT; Patil S; Goodman KA; Garcia-Aguilar J Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):924-930. PubMed ID: 28333014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]